Long-term survival after surgical management of neuroendocrine hepatic metastases

HPB

Volumn 12, Issue 6, 2010, Pages 427-433

  Glazer, Evan S ^a   Tseng, Jennifer F ^b   Al Refaie, Waddah ^b   Solorzano, Carmen C ^c   Liu, Ping ^a   Willborn, Katherine A ^a   Abdalla, Eddie K ^a   Vauthey, Jean Nicolas ^a   Curley, Steven A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoid; Liver metastases; Liver resection; Nneuroendocrine; Radiofrequency ablation; Survival

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHOLECYSTECTOMY; CONFIDENCE INTERVAL; DATA BASE; DYSPHAGIA; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; ILEUS; KIDNEY FAILURE; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LIVER VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; RADIOFREQUENCY ABLATION; SCHOOL CHILD; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR RECURRENCE; URINARY DYSFUNCTION; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 77956894258     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00198.x     Document Type: Article

References (18)

1. Modlin IM, Sandor A, Tang LH, Kidd M, Zelterman D. (1997) A 40-year analysis of 265 gastric carcinoids. Am J Gastroenterol 92:633-638.
2. Ahmed A, Turner G, King B, Jones L, Culliford D, McCance D et al. (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16:885-894.
3. Zeegen R, Rothwell-Jackson R, Sandler M. (1969) Massive hepatic resection for the carcinoid syndrome. Gut 10:617-622.
4. Landry CS, Scoggins CR, McMasters KM, Martin RC 2nd. (2008) Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 97:253-258.
5. Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF et al. (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115:741-751.
6. Van Gompel JJ, Sippel RS, Warner TF, Chen H. (2004) Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg 28:387-392.
7. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. (1995) Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169: 36-42, discussion 42-43
8. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA et al. (2009) Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16:836-847.
9. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A. (2010) AJCC Cancer Staging Manual, 7th edn. New York: Springer.
10. Curley SA. (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10:338-347.
11. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1-8.
12. Belgihiti J, Clavien PA, Gadzijev E, Garden JO, Lau W, Makuuchi M et al. (2000) The brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford) 2:333-339.
13. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213.
14. Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ et al. (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26:5344-5351.
15. Ahlman H, Westberg G, Wangberg B, Nilsson O, Tylen U, Schersten T et al. (1996) Treatment of liver metastases of carcinoid tumors. World J Surg 20:196-202.
16. Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H et al. (2008) Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg 12:1951-1960.
17. Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y et al. (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190:432-445.
18. Rinke A, Muller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M et al. (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27:4656-4663